References
Original article
Janjigian, Y. Y. et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature https://doi.org/10.1038/s41586-021-04161-3 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Pembrolizumab for HER2+ gastric cancer. Nat Rev Clin Oncol 19, 150 (2022). https://doi.org/10.1038/s41571-021-00594-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00594-x
- Springer Nature Limited
This article is cited by
-
Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
Journal of Cancer Research and Clinical Oncology (2024)